|
Volumn 29, Issue 4, 1997, Pages 2234-2237
|
Human gene therapy with myoblast transfer
a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
DYSTROPHIN;
ADOLESCENT;
BICEPS BRACHII MUSCLE;
CELL TRANSFER;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DUCHENNE MUSCULAR DYSTROPHY;
GENE THERAPY;
GENETIC TRANSDUCTION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MYOBLAST;
PRIORITY JOURNAL;
QUADRICEPS FEMORIS MUSCLE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
CELL TRANSPLANTATION;
CELLS, CULTURED;
CHILD;
DOUBLE-BLIND METHOD;
DYSTROPHIN;
GENE THERAPY;
HUMANS;
IMMUNOSUPPRESSION;
MALE;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHIES;
VITAL CAPACITY;
|
EID: 12644261416
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(97)00312-6 Document Type: Conference Paper |
Times cited : (19)
|
References (17)
|